Joseph D. Miller

1.3k total citations · 1 hit paper
18 papers, 861 citations indexed

About

Joseph D. Miller is a scholar working on Cellular and Molecular Neuroscience, Infectious Diseases and Cognitive Neuroscience. According to data from OpenAlex, Joseph D. Miller has authored 18 papers receiving a total of 861 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cellular and Molecular Neuroscience, 4 papers in Infectious Diseases and 4 papers in Cognitive Neuroscience. Recurrent topics in Joseph D. Miller's work include Neuroscience and Neuropharmacology Research (5 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Joseph D. Miller is often cited by papers focused on Neuroscience and Neuropharmacology Research (5 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Joseph D. Miller collaborates with scholars based in United States, France and Canada. Joseph D. Miller's co-authors include H. Craig Heller, Rebecca A. Prosser, Dwight C. German, Howard P. Roffwarg, Brian A. McMillen, Samuel G. Speciale, Osama A. Abulseoud, Ruth Link‐Gelles, Daniel P. Holschneider and Amadea Britton and has published in prestigious journals such as PEDIATRICS, Brain Research and Emerging infectious diseases.

In The Last Decade

Joseph D. Miller

18 papers receiving 829 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Early Estimates of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co-Circulating Omicron Variants Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, September 2023–January 2024

2024 80 citations Ruth Link‐Gelles, Allison Avrich Ciesla et al. MMWR Morbidity and Mortality Weekly Report profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joseph D. Miller United States	13	374	309	268	161	125	18	861
Luis I. García Mexico	18	155 0.4×	101 0.3×	77 0.3×	257 1.6×	247 2.0×	85	1.4k
Zoltán Péterfi Hungary	17	124 0.3×	190 0.6×	165 0.6×	180 1.1×	181 1.4×	52	738
Reija Alén Finland	12	90 0.2×	333 1.1×	108 0.4×	61 0.4×	152 1.2×	14	700
Anniina Alakuijala Finland	16	94 0.3×	357 1.2×	112 0.4×	38 0.2×	77 0.6×	34	680
Fahed Hakim Israel	14	66 0.2×	73 0.2×	54 0.2×	123 0.8×	134 1.1×	34	920
Anish Arora Canada	13	271 0.7×	111 0.4×	19 0.1×	56 0.3×	251 2.0×	40	752
David L. Stewart United States	13	251 0.7×	404 1.3×	20 0.1×	42 0.3×	192 1.5×	19	734
Junichi Oki Japan	15	48 0.1×	170 0.6×	59 0.2×	90 0.6×	131 1.0×	51	747
Claire André France	15	31 0.1×	329 1.1×	132 0.5×	15 0.1×	65 0.5×	47	832
Gretchen Hermes United States	14	204 0.5×	110 0.4×	34 0.1×	15 0.1×	206 1.6×	23	807

Countries citing papers authored by Joseph D. Miller

Since Specialization

Citations

This map shows the geographic impact of Joseph D. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph D. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph D. Miller more than expected).

Fields of papers citing papers by Joseph D. Miller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph D. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph D. Miller. The network helps show where Joseph D. Miller may publish in the future.

Co-authorship network of co-authors of Joseph D. Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph D. Miller. A scholar is included among the top collaborators of Joseph D. Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph D. Miller. Joseph D. Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Link‐Gelles, Ruth, Allison Avrich Ciesla, Josephine Mak, et al.. (2024). Early Estimates of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co-Circulating Omicron Variants Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, September 2023–January 2024. MMWR Morbidity and Mortality Weekly Report. 73(4). 77–83. 80 indexed citations breakdown →

Scobie, Heather M., Akilah R. Ali, Philip Shirk, et al.. (2023). Spike Gene Target Amplification in a Diagnostic Assay as a Marker for Public Health Monitoring of Emerging SARS-CoV-2 Variants — United States, November 2021–January 2023. MMWR Morbidity and Mortality Weekly Report. 72(5). 125–127. 6 indexed citations

Link‐Gelles, Ruth, Allison Avrich Ciesla, Katherine E. Fleming-Dutra, et al.. (2022). Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022. MMWR Morbidity and Mortality Weekly Report. 71(48). 1526–1530. 88 indexed citations

Miller, Mark F., et al.. (2021). Community-Based Testing Sites for SARS-CoV-2 — United States, March 2020–November 2021. MMWR Morbidity and Mortality Weekly Report. 70(49). 1706–1711. 10 indexed citations

Isaac‐Renton, Judith L., Natalie Prystajecky, Martin Petric, et al.. (2012). Use of Lean Response to Improve Pandemic Influenza Surge in Public Health Laboratories. Emerging infectious diseases. 18(1). 57–62. 12 indexed citations

Abulseoud, Osama A., Joseph D. Miller, Jinhua Wu, Doo‐Sup Choi, & Daniel P. Holschneider. (2012). Ceftriaxone upregulates the glutamate transporter in medial prefrontal cortex and blocks reinstatement of methamphetamine seeking in a condition place preference paradigm. Brain Research. 1456. 14–21. 68 indexed citations

Tubbs, R. Shane, Mitchel Muhleman, Joseph D. Miller, et al.. (2011). Cervical ribs with neurological sequelae in children: a case series. Child s Nervous System. 28(4). 605–608. 9 indexed citations

Gallaher, Timothy K., et al.. (2008). Multilineage hematopoietic recovery with concomitant antitumor effects using low dose Interleukin-12 in myelosuppressed tumor-bearing mice. Journal of Translational Medicine. 6(1). 26–26. 13 indexed citations

Prosser, Rebecca A., H. Craig Heller, & Joseph D. Miller. (1994). Serotonergic phase advances of the mammalian circadian clock involve protein kinase A and K+ channel opening. Brain Research. 644(1). 67–73. 63 indexed citations

10.

Winton, Tim, Joseph D. Miller, Masina Scavuzzo, J Maurer, & G. Alexander Patterson. (1991). Donor selection for pulmonary transplantation. Transplantation Proceedings. 23(5). 2472–2474. 10 indexed citations

11.

Prosser, Rebecca A., Joseph D. Miller, & H. Craig Heller. (1990). A serotonin agonist phase-shifts the circadian clock in the suprachiasmatic nuclei in vitro. Brain Research. 534(1-2). 336–339. 134 indexed citations

12.

Miller, Joseph D., B.A. McMillen, Mona M. McConnaughey, Helen L. Williams, & Charles A. Fuller. (1989). Effects of microgravity on brain neurotransmitter receptors. European Journal of Pharmacology. 161(2-3). 165–171. 15 indexed citations

13.

Miller, Joseph D. & Kenneth R. Brizzee. (1987). The anti-emetic properties of 1-sulpiride in a ground-based model of space motion sickness. Life Sciences. 41(15). 1815–1822. 11 indexed citations

14.

Speciale, Samuel G., Joseph D. Miller, Brian A. McMillen, & Dwight C. German. (1986). Activation of specific central dopamine pathways: Locomotion and footshock. Brain Research Bulletin. 16(1). 33–38. 50 indexed citations

15.

Miller, Joseph D., Samuel G. Speciale, Brian A. McMillen, & Dwight C. German. (1984). Naloxone antagonism of stress-induced augmentation of frontal cortex dopamine metabolism. European Journal of Pharmacology. 98(3-4). 437–439. 38 indexed citations

16.

Miller, Joseph D., et al.. (1983). Dopamine metabolism and receptor sensitivity in rat brain after REM sleep deprivation. Pharmacology Biochemistry and Behavior. 18(4). 509–513. 31 indexed citations

17.

Miller, Joseph D., et al.. (1983). Activity of mesencephalic dopamine and non-dopamine neurons across stages of sleep and waking in the rat. Brain Research. 273(1). 133–141. 201 indexed citations

18.

Miller, Joseph D., et al.. (1971). THE PREPARATION, UTILIZATION, AND EVALUATION OF A REGISTERED NURSE TRAINED TO GIVE TELEPHONE ADVICE IN A PRIVATE PEDIATRIC OFFICE. PEDIATRICS. 47(6). 1051–1055. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact